TRIB
Trinity Biotech
TRIB
TRIB
67 hedge funds and large institutions have $93.7M invested in Trinity Biotech in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $201K
Holders
67
Holding in Top 10
1
Calls
–
Puts
$201K
Top Buyers
| 1 | +$1.14M | |
| 2 | +$915K | |
| 3 | +$687K | |
| 4 |
TA
Teton Advisors
Rye,
New York
|
+$542K |
| 5 |
FM
Fondren Management
Houston,
Texas
|
+$536K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$1.15M | |
| 3 | -$753K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$674K |
| 5 |
GCM
Goldman Capital Management
New York
|
-$584K |